Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Acute Respiratory Distress Syndrome as the Initial Clinical Manifestation of an Antisynthetase Syndrome

  • Kim, Seo-Hyun (Department of Internal Medicine, Inje University Seoul Paik Hospital) ;
  • Park, I-Nae (Department of Internal Medicine, Inje University Seoul Paik Hospital)
  • Received : 2015.06.01
  • Accepted : 2015.09.19
  • Published : 2016.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Antisynthetase syndrome has been recognized as an important cause of autoimmune inflammatory myopathy in a subset of patients with polymyositis and dermatomyositis. It is associated with serum antibody to aminoacyl-transfer RNA synthetases and is characterized by a constellation of manifestations, including fever, myositis, interstitial lung disease, mechanic's hand-like cutaneous involvement, Raynaud phenomenon, and polyarthritis. Lung disease is the presenting feature in 50% of the cases. We report a case of a 60-year-old female with acute respiratory distress syndrome (ARDS), which later proved to be an unexpected and initial manifestation of anti-Jo-1 antibody-positive antisynthetase syndrome. The present case showed resolution of ARDS after treatment with high-dose corticosteroids. Given that steroids are not greatly beneficial in the treatment of ARDS, it is likely that the improvement of the respiratory symptoms in this patient also resulted from the prompt suppression of the inflammatory systemic response by corticosteroids.

Keywords

References

  1. Fathi M, Vikgren J, Boijsen M, Tylen U, Jorfeldt L, Tornling G, et al. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum 2008;59:677-85. https://doi.org/10.1002/art.23571
  2. Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004;63:297-301. https://doi.org/10.1136/ard.2003.006122
  3. Saketkoo LA, Ascherman DP, Cottin V, Christopher-Stine L, Danoff SK, Oddis CV. Interstitial lung disease in idiopathic inflammatory myopathy. Curr Rheumatol Rev 2010;6:108-19. https://doi.org/10.2174/157339710791330740
  4. Targoff IN. Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am 1994;20:857-80.
  5. Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 1996;26:459-67. https://doi.org/10.1016/S0049-0172(96)80026-6
  6. Tillie-Leblond I, Wislez M, Valeyre D, Crestani B, Rabbat A, Israel-Biet D, et al. Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax 2008;63:53-9. https://doi.org/10.1136/thx.2006.069237
  7. Koreeda Y, Higashimoto I, Yamamoto M, Takahashi M, Kaji K, Fujimoto M, et al. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Intern Med 2010;49:361-9. https://doi.org/10.2169/internalmedicine.49.2889
  8. Bajocchi G, Piro R, Lombardini C, Cavazza A, Facciolongo N. Acute respiratory distress syndrome: an undercover antisynthetase syndrome: a case report and a review of the literature. Clin Exp Rheumatol 2012;30:424-8.
  9. Polosa R, Di Mauro C, Spampinato B, Castelli L, D'Amico G, Edwards CJ, et al. A patient with antihistidyl-tRNA synthetase positive polymyositis presenting as acute respiratory distress syndrome. J Clin Rheumatol 2008;14:219-21. https://doi.org/10.1097/RHU.0b013e31817de0d4
  10. Richards TJ, Eggebeen A, Gibson K, Yousem S, Fuhrman C, Gochuico BR, et al. Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum 2009;60:2183-92. https://doi.org/10.1002/art.24631
  11. Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002;47:614-22. https://doi.org/10.1002/art.10794
  12. Huh JW, Kim DS, Lee CK, Yoo B, Seo JB, Kitaichi M, et al. Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med 2007;101:1761-9. https://doi.org/10.1016/j.rmed.2007.02.017
  13. Yousem SA, Gibson K, Kaminski N, Oddis CV, Ascherman DP. The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome. Mod Pathol 2010;23:874-80. https://doi.org/10.1038/modpathol.2010.65
  14. Lee CS, Chen TL, Tzen CY, Lin FJ, Peng MJ, Wu CL, et al. Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol 2002;21:391-6. https://doi.org/10.1007/s100670200104
  15. Guglielmi S, Merz TM, Gugger M, Suter C, Nicod LP. Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus. Eur Respir J 2008;31:213-7. https://doi.org/10.1183/09031936.00014707

Cited by

  1. Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies vol.44, pp.7, 2016, https://doi.org/10.3899/jrheum.161480
  2. Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study vol.8, pp.1, 2016, https://doi.org/10.1186/s13613-018-0433-3
  3. Nintedanib and intensive immunosuppressive therapy to treat rapidly progressive interstitial lung disease presenting anti-ARS antibodies vol.31, pp.None, 2016, https://doi.org/10.1016/j.rmcr.2020.101272
  4. Antisynthetase syndrome – much more than just a myopathy vol.51, pp.1, 2016, https://doi.org/10.1016/j.semarthrit.2020.09.020